| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surgical Wound Infection | 13 | 2023 | 450 | 2.980 |
Why?
|
| Elective Surgical Procedures | 7 | 2020 | 250 | 1.990 |
Why?
|
| Surgical Mesh | 8 | 2013 | 209 | 1.640 |
Why?
|
| Herniorrhaphy | 5 | 2013 | 169 | 1.610 |
Why?
|
| Cross Infection | 5 | 2015 | 544 | 1.360 |
Why?
|
| Laparoscopy | 12 | 2018 | 1225 | 1.080 |
Why?
|
| Hernia, Ventral | 5 | 2013 | 159 | 0.990 |
Why?
|
| Catheter-Related Infections | 2 | 2020 | 270 | 0.970 |
Why?
|
| Postoperative Complications | 14 | 2020 | 5542 | 0.940 |
Why?
|
| Crush Injuries | 1 | 2023 | 6 | 0.930 |
Why?
|
| Operating Rooms | 3 | 2017 | 122 | 0.870 |
Why?
|
| Intensive Care Units | 3 | 2017 | 717 | 0.870 |
Why?
|
| Hernia, Abdominal | 3 | 2018 | 41 | 0.870 |
Why?
|
| General Surgery | 8 | 2011 | 326 | 0.860 |
Why?
|
| Guideline Adherence | 2 | 2020 | 636 | 0.850 |
Why?
|
| Pressure Ulcer | 1 | 2023 | 106 | 0.850 |
Why?
|
| Surgical Procedures, Operative | 5 | 2017 | 383 | 0.840 |
Why?
|
| Anti-Bacterial Agents | 7 | 2018 | 2992 | 0.820 |
Why?
|
| Preoperative Care | 5 | 2020 | 1529 | 0.810 |
Why?
|
| Laparotomy | 3 | 2011 | 211 | 0.800 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 4 | 2013 | 308 | 0.780 |
Why?
|
| Safety Management | 2 | 2020 | 132 | 0.740 |
Why?
|
| Urinary Catheters | 1 | 2020 | 31 | 0.740 |
Why?
|
| Staphylococcal Infections | 4 | 2013 | 672 | 0.730 |
Why?
|
| Antibiotic Prophylaxis | 3 | 2018 | 181 | 0.730 |
Why?
|
| Health Facilities | 1 | 2020 | 79 | 0.720 |
Why?
|
| Hernia, Inguinal | 4 | 2009 | 49 | 0.710 |
Why?
|
| Risk Management | 1 | 2020 | 107 | 0.700 |
Why?
|
| Veterans | 8 | 2022 | 1641 | 0.690 |
Why?
|
| Hospital Mortality | 7 | 2020 | 1274 | 0.660 |
Why?
|
| Medical Errors | 1 | 2020 | 219 | 0.630 |
Why?
|
| Quality of Health Care | 2 | 2020 | 621 | 0.620 |
Why?
|
| Data Collection | 1 | 2020 | 620 | 0.610 |
Why?
|
| Catheters, Indwelling | 1 | 2020 | 374 | 0.600 |
Why?
|
| Nurse Specialists | 1 | 2017 | 1 | 0.600 |
Why?
|
| Colonic Neoplasms | 6 | 2018 | 1390 | 0.600 |
Why?
|
| Advanced Practice Nursing | 1 | 2017 | 14 | 0.590 |
Why?
|
| Soft Tissue Infections | 3 | 2011 | 102 | 0.580 |
Why?
|
| Medical Futility | 1 | 2017 | 54 | 0.580 |
Why?
|
| Nurse's Role | 1 | 2017 | 42 | 0.580 |
Why?
|
| Health Care Costs | 3 | 2017 | 674 | 0.580 |
Why?
|
| Pneumonia, Ventilator-Associated | 2 | 2014 | 50 | 0.570 |
Why?
|
| Collagen | 3 | 2009 | 752 | 0.560 |
Why?
|
| United States Department of Veterans Affairs | 4 | 2017 | 605 | 0.560 |
Why?
|
| Orthopedic Procedures | 2 | 2015 | 146 | 0.550 |
Why?
|
| Urinary Tract Infections | 1 | 2020 | 321 | 0.540 |
Why?
|
| Perioperative Care | 2 | 2012 | 451 | 0.540 |
Why?
|
| Hospitals, Veterans | 10 | 2017 | 397 | 0.540 |
Why?
|
| Retrospective Studies | 41 | 2022 | 37905 | 0.540 |
Why?
|
| Health Resources | 1 | 2017 | 168 | 0.530 |
Why?
|
| Length of Stay | 12 | 2017 | 1900 | 0.530 |
Why?
|
| Rectal Neoplasms | 4 | 2018 | 1202 | 0.530 |
Why?
|
| Decontamination | 1 | 2015 | 16 | 0.530 |
Why?
|
| Methicillin Resistance | 2 | 2007 | 147 | 0.510 |
Why?
|
| Mandatory Reporting | 1 | 2014 | 24 | 0.510 |
Why?
|
| Internship and Residency | 6 | 2008 | 1375 | 0.480 |
Why?
|
| Oxazolidinones | 1 | 2014 | 60 | 0.470 |
Why?
|
| Quality Improvement | 2 | 2020 | 851 | 0.470 |
Why?
|
| Ceftazidime | 1 | 2014 | 57 | 0.470 |
Why?
|
| Leadership | 2 | 2008 | 254 | 0.470 |
Why?
|
| Cephalosporins | 1 | 2014 | 148 | 0.460 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 524 | 0.460 |
Why?
|
| Patient Readmission | 2 | 2017 | 548 | 0.450 |
Why?
|
| Acetamides | 1 | 2014 | 113 | 0.450 |
Why?
|
| Emergencies | 2 | 2011 | 202 | 0.450 |
Why?
|
| Colostomy | 1 | 2013 | 70 | 0.440 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 295 | 0.440 |
Why?
|
| Pneumonia, Bacterial | 1 | 2014 | 130 | 0.440 |
Why?
|
| Middle Aged | 48 | 2020 | 86204 | 0.440 |
Why?
|
| Clinical Protocols | 1 | 2015 | 467 | 0.440 |
Why?
|
| Bacteremia | 2 | 2015 | 689 | 0.420 |
Why?
|
| Humans | 84 | 2023 | 261506 | 0.420 |
Why?
|
| Incidence | 10 | 2020 | 5673 | 0.420 |
Why?
|
| Skin, Artificial | 2 | 2009 | 25 | 0.410 |
Why?
|
| Abdominal Cavity | 1 | 2011 | 20 | 0.410 |
Why?
|
| Vas Deferens | 1 | 2011 | 21 | 0.410 |
Why?
|
| Vasectomy | 1 | 2011 | 15 | 0.410 |
Why?
|
| Fasciotomy | 1 | 2011 | 43 | 0.410 |
Why?
|
| Hernia, Umbilical | 3 | 2008 | 36 | 0.400 |
Why?
|
| Male | 56 | 2020 | 123000 | 0.400 |
Why?
|
| Staphylococcus aureus | 2 | 2007 | 548 | 0.390 |
Why?
|
| Abdomen, Acute | 1 | 2010 | 36 | 0.380 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 761 | 0.380 |
Why?
|
| Hepatitis C, Chronic | 1 | 2015 | 451 | 0.370 |
Why?
|
| Polypropylenes | 2 | 2007 | 25 | 0.370 |
Why?
|
| Follow-Up Studies | 15 | 2015 | 14889 | 0.370 |
Why?
|
| Electric Countershock | 1 | 2010 | 71 | 0.370 |
Why?
|
| Perioperative Period | 1 | 2010 | 155 | 0.360 |
Why?
|
| Aged | 38 | 2020 | 70117 | 0.350 |
Why?
|
| Digestive System Diseases | 1 | 2009 | 35 | 0.350 |
Why?
|
| Texas | 12 | 2020 | 6311 | 0.350 |
Why?
|
| Biocompatible Materials | 2 | 2007 | 202 | 0.350 |
Why?
|
| Mental Disorders | 1 | 2016 | 862 | 0.340 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 1148 | 0.340 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2010 | 226 | 0.340 |
Why?
|
| Urogenital Abnormalities | 1 | 2011 | 174 | 0.340 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2018 | 500 | 0.330 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 1303 | 0.320 |
Why?
|
| Pain, Postoperative | 2 | 2013 | 610 | 0.310 |
Why?
|
| Treatment Outcome | 22 | 2018 | 32848 | 0.310 |
Why?
|
| Female | 47 | 2020 | 141928 | 0.310 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2007 | 53 | 0.300 |
Why?
|
| Recurrence | 9 | 2013 | 4758 | 0.300 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 915 | 0.300 |
Why?
|
| Abdomen | 1 | 2009 | 332 | 0.290 |
Why?
|
| Interpersonal Relations | 2 | 2008 | 290 | 0.290 |
Why?
|
| Gangrene | 3 | 2004 | 28 | 0.280 |
Why?
|
| Professional Competence | 1 | 2007 | 136 | 0.280 |
Why?
|
| Logistic Models | 9 | 2015 | 3441 | 0.270 |
Why?
|
| Multivariate Analysis | 6 | 2015 | 4298 | 0.270 |
Why?
|
| United States | 15 | 2018 | 15433 | 0.260 |
Why?
|
| Inservice Training | 1 | 2005 | 78 | 0.260 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2007 | 323 | 0.260 |
Why?
|
| Risk Assessment | 8 | 2020 | 6869 | 0.250 |
Why?
|
| Colectomy | 5 | 2010 | 288 | 0.250 |
Why?
|
| Sepsis | 3 | 2009 | 652 | 0.250 |
Why?
|
| Cholecystitis, Acute | 1 | 2004 | 17 | 0.250 |
Why?
|
| Abdominal Wall | 1 | 2007 | 184 | 0.250 |
Why?
|
| Anastomotic Leak | 2 | 2018 | 71 | 0.250 |
Why?
|
| Patient Care Team | 2 | 2011 | 795 | 0.250 |
Why?
|
| Postoperative Hemorrhage | 2 | 2019 | 162 | 0.250 |
Why?
|
| Practice Guidelines as Topic | 3 | 2012 | 2403 | 0.250 |
Why?
|
| Analysis of Variance | 6 | 2016 | 2307 | 0.240 |
Why?
|
| Liver Failure, Acute | 1 | 2005 | 88 | 0.240 |
Why?
|
| Infection Control | 2 | 2018 | 270 | 0.240 |
Why?
|
| Heart Rate | 1 | 2007 | 737 | 0.240 |
Why?
|
| Clinical Competence | 3 | 2017 | 1270 | 0.240 |
Why?
|
| Digestive System Surgical Procedures | 4 | 2014 | 275 | 0.240 |
Why?
|
| Emergency Treatment | 1 | 2004 | 105 | 0.240 |
Why?
|
| Interprofessional Relations | 1 | 2005 | 213 | 0.230 |
Why?
|
| Spider Bites | 1 | 2003 | 2 | 0.230 |
Why?
|
| Lithium | 1 | 2003 | 71 | 0.230 |
Why?
|
| Multiple Organ Failure | 2 | 2005 | 177 | 0.230 |
Why?
|
| Suture Techniques | 4 | 2012 | 319 | 0.220 |
Why?
|
| Atrial Fibrillation | 1 | 2010 | 719 | 0.220 |
Why?
|
| Hyperparathyroidism | 1 | 2003 | 93 | 0.220 |
Why?
|
| Liver Cirrhosis | 2 | 2011 | 941 | 0.220 |
Why?
|
| Parathyroid Glands | 1 | 2003 | 127 | 0.210 |
Why?
|
| Pleurodesis | 1 | 2002 | 71 | 0.210 |
Why?
|
| Comorbidity | 3 | 2016 | 2352 | 0.200 |
Why?
|
| APACHE | 3 | 2010 | 93 | 0.200 |
Why?
|
| Doxycycline | 1 | 2002 | 178 | 0.200 |
Why?
|
| Parathyroid Neoplasms | 1 | 2003 | 185 | 0.200 |
Why?
|
| Attitude of Health Personnel | 1 | 2008 | 918 | 0.200 |
Why?
|
| Shock | 1 | 2022 | 88 | 0.200 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2012 | 129 | 0.190 |
Why?
|
| Communication | 1 | 2007 | 876 | 0.190 |
Why?
|
| Adult | 19 | 2018 | 77950 | 0.190 |
Why?
|
| Antidepressive Agents | 1 | 2003 | 332 | 0.180 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2018 | 600 | 0.180 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2013 | 158 | 0.180 |
Why?
|
| Operative Time | 2 | 2018 | 217 | 0.180 |
Why?
|
| Cohort Studies | 7 | 2020 | 9244 | 0.180 |
Why?
|
| Digestive System Neoplasms | 2 | 2014 | 82 | 0.170 |
Why?
|
| Hemostasis, Surgical | 1 | 2019 | 48 | 0.170 |
Why?
|
| Nutrition Assessment | 1 | 2020 | 169 | 0.170 |
Why?
|
| Endosonography | 1 | 2002 | 536 | 0.170 |
Why?
|
| Curriculum | 1 | 2004 | 860 | 0.170 |
Why?
|
| Time Factors | 6 | 2018 | 12926 | 0.170 |
Why?
|
| Reoperation | 3 | 2013 | 1382 | 0.170 |
Why?
|
| Respiratory Insufficiency | 1 | 2002 | 330 | 0.170 |
Why?
|
| Anus Neoplasms | 2 | 2018 | 411 | 0.170 |
Why?
|
| Critical Care | 3 | 2015 | 770 | 0.170 |
Why?
|
| Hemostatics | 1 | 2019 | 88 | 0.170 |
Why?
|
| Biopsy, Needle | 1 | 2002 | 1363 | 0.160 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2010 | 121 | 0.160 |
Why?
|
| Risk Factors | 14 | 2013 | 17523 | 0.160 |
Why?
|
| Colon, Ascending | 1 | 2018 | 12 | 0.160 |
Why?
|
| Neomycin | 1 | 2018 | 38 | 0.160 |
Why?
|
| Colon, Sigmoid | 1 | 2018 | 42 | 0.160 |
Why?
|
| Cathartics | 1 | 2018 | 42 | 0.160 |
Why?
|
| Adenoma | 1 | 2003 | 716 | 0.160 |
Why?
|
| Hepatocytes | 3 | 2005 | 351 | 0.160 |
Why?
|
| Episode of Care | 1 | 2017 | 7 | 0.160 |
Why?
|
| Citric Acid | 1 | 2018 | 54 | 0.150 |
Why?
|
| Cognitive Dissonance | 1 | 2017 | 3 | 0.150 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2022 | 1237 | 0.150 |
Why?
|
| Malnutrition | 1 | 2020 | 218 | 0.150 |
Why?
|
| Arthroplasty, Replacement | 1 | 2017 | 27 | 0.150 |
Why?
|
| Cardiovascular Diseases | 2 | 2008 | 2195 | 0.150 |
Why?
|
| Metronidazole | 1 | 2018 | 149 | 0.150 |
Why?
|
| Cultural Characteristics | 1 | 2017 | 70 | 0.150 |
Why?
|
| Organometallic Compounds | 1 | 2018 | 191 | 0.150 |
Why?
|
| Social Responsibility | 1 | 2017 | 92 | 0.150 |
Why?
|
| Probability | 4 | 2004 | 866 | 0.140 |
Why?
|
| Personality | 1 | 2017 | 116 | 0.130 |
Why?
|
| Statistics, Nonparametric | 3 | 2013 | 980 | 0.130 |
Why?
|
| Survival Rate | 5 | 2018 | 12221 | 0.130 |
Why?
|
| Databases, Factual | 3 | 2018 | 2218 | 0.130 |
Why?
|
| Sampling Studies | 2 | 2004 | 170 | 0.130 |
Why?
|
| Linezolid | 1 | 2014 | 64 | 0.120 |
Why?
|
| Anesthesia, General | 2 | 2007 | 239 | 0.120 |
Why?
|
| Coronary Artery Bypass | 1 | 2019 | 708 | 0.120 |
Why?
|
| Surveys and Questionnaires | 4 | 2008 | 5687 | 0.120 |
Why?
|
| Perineum | 1 | 2014 | 107 | 0.120 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 2 | 2004 | 29 | 0.120 |
Why?
|
| Administration, Oral | 1 | 2018 | 1544 | 0.120 |
Why?
|
| Morbidity | 1 | 2015 | 397 | 0.120 |
Why?
|
| Liver Failure | 2 | 2005 | 140 | 0.120 |
Why?
|
| Prospective Studies | 7 | 2015 | 12873 | 0.120 |
Why?
|
| Sex Factors | 2 | 2017 | 2139 | 0.120 |
Why?
|
| Anal Canal | 1 | 2014 | 238 | 0.120 |
Why?
|
| Drug Therapy | 1 | 2014 | 205 | 0.110 |
Why?
|
| Administration, Intravenous | 1 | 2014 | 249 | 0.110 |
Why?
|
| Enterococcus | 1 | 2013 | 59 | 0.110 |
Why?
|
| Staphylococcus epidermidis | 1 | 2013 | 61 | 0.110 |
Why?
|
| Abdominal Wound Closure Techniques | 1 | 2013 | 40 | 0.110 |
Why?
|
| Organ Sparing Treatments | 1 | 2014 | 277 | 0.110 |
Why?
|
| Fasciitis, Necrotizing | 2 | 2011 | 36 | 0.110 |
Why?
|
| Cause of Death | 1 | 2015 | 752 | 0.110 |
Why?
|
| Hand-Assisted Laparoscopy | 1 | 2012 | 7 | 0.110 |
Why?
|
| Polytetrafluoroethylene | 1 | 2013 | 113 | 0.110 |
Why?
|
| Equipment Design | 3 | 2019 | 1204 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 2315 | 0.110 |
Why?
|
| Wound Closure Techniques | 1 | 2012 | 28 | 0.100 |
Why?
|
| Orchiopexy | 1 | 2011 | 2 | 0.100 |
Why?
|
| Odds Ratio | 2 | 2017 | 2316 | 0.100 |
Why?
|
| Substance-Related Disorders | 1 | 2016 | 524 | 0.100 |
Why?
|
| Vascular Surgical Procedures | 1 | 2018 | 655 | 0.100 |
Why?
|
| Robotic Surgical Procedures | 1 | 2018 | 481 | 0.100 |
Why?
|
| Program Development | 2 | 2009 | 261 | 0.100 |
Why?
|
| Long-Term Care | 1 | 2011 | 83 | 0.100 |
Why?
|
| Chemoradiotherapy | 2 | 2018 | 1946 | 0.100 |
Why?
|
| Liver Neoplasms | 3 | 2018 | 4557 | 0.100 |
Why?
|
| Colorectal Neoplasms | 3 | 2012 | 3578 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2015 | 698 | 0.100 |
Why?
|
| Coronary Artery Disease | 1 | 2019 | 1011 | 0.100 |
Why?
|
| Hepatectomy | 3 | 2014 | 1011 | 0.100 |
Why?
|
| Hospitals, University | 1 | 2011 | 209 | 0.100 |
Why?
|
| Amiodarone | 1 | 2010 | 42 | 0.090 |
Why?
|
| Rectum | 2 | 2012 | 467 | 0.090 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2011 | 136 | 0.090 |
Why?
|
| Education, Medical, Graduate | 2 | 2008 | 671 | 0.090 |
Why?
|
| 2-Propanol | 1 | 2010 | 10 | 0.090 |
Why?
|
| Ambulatory Care | 1 | 2014 | 554 | 0.090 |
Why?
|
| Abscess | 1 | 2011 | 177 | 0.090 |
Why?
|
| Povidone-Iodine | 1 | 2010 | 21 | 0.090 |
Why?
|
| Age Factors | 4 | 2017 | 5377 | 0.090 |
Why?
|
| Aged, 80 and over | 8 | 2014 | 29902 | 0.090 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 604 | 0.090 |
Why?
|
| Population Surveillance | 2 | 2011 | 627 | 0.090 |
Why?
|
| Chronic Pain | 1 | 2013 | 238 | 0.090 |
Why?
|
| Silver Sulfadiazine | 1 | 2009 | 15 | 0.090 |
Why?
|
| Chlorhexidine | 1 | 2010 | 88 | 0.090 |
Why?
|
| Anxiety | 1 | 2016 | 1179 | 0.090 |
Why?
|
| Robotics | 1 | 2013 | 359 | 0.090 |
Why?
|
| Rectal Diseases | 1 | 2009 | 55 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2013 | 953 | 0.080 |
Why?
|
| Colon | 2 | 2012 | 670 | 0.080 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2009 | 111 | 0.080 |
Why?
|
| Prognosis | 6 | 2014 | 21713 | 0.080 |
Why?
|
| Alcoholism | 1 | 2011 | 285 | 0.080 |
Why?
|
| Colonic Diseases | 1 | 2009 | 71 | 0.080 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 251 | 0.080 |
Why?
|
| Workload | 2 | 2008 | 198 | 0.080 |
Why?
|
| Ischemia | 1 | 2011 | 391 | 0.080 |
Why?
|
| Fluid Therapy | 1 | 2009 | 182 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2014 | 2588 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2011 | 4320 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 577 | 0.080 |
Why?
|
| Surgery Department, Hospital | 1 | 2008 | 30 | 0.080 |
Why?
|
| Academic Medical Centers | 2 | 2008 | 672 | 0.080 |
Why?
|
| Competency-Based Education | 1 | 2008 | 72 | 0.080 |
Why?
|
| Blood-Borne Pathogens | 1 | 2006 | 13 | 0.070 |
Why?
|
| Needlestick Injuries | 1 | 2006 | 7 | 0.070 |
Why?
|
| Intestines | 1 | 2011 | 686 | 0.070 |
Why?
|
| Referral and Consultation | 2 | 2014 | 899 | 0.070 |
Why?
|
| Cooperative Behavior | 1 | 2008 | 313 | 0.070 |
Why?
|
| Cyclonic Storms | 1 | 2008 | 88 | 0.070 |
Why?
|
| Depression | 1 | 2016 | 1715 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2012 | 2292 | 0.070 |
Why?
|
| Adenocarcinoma | 3 | 2018 | 7789 | 0.070 |
Why?
|
| Patient Safety | 1 | 2012 | 649 | 0.070 |
Why?
|
| Cross Circulation | 1 | 2005 | 5 | 0.070 |
Why?
|
| Hemoperfusion | 1 | 2005 | 5 | 0.070 |
Why?
|
| Cancer Care Facilities | 1 | 2011 | 884 | 0.070 |
Why?
|
| Debridement | 2 | 2005 | 123 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 8865 | 0.070 |
Why?
|
| Liver, Artificial | 1 | 2005 | 8 | 0.070 |
Why?
|
| Dialysis | 1 | 2005 | 23 | 0.070 |
Why?
|
| Education, Nursing | 1 | 2005 | 18 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2004 | 4892 | 0.070 |
Why?
|
| Hemodiafiltration | 1 | 2005 | 18 | 0.070 |
Why?
|
| Chi-Square Distribution | 3 | 2017 | 1323 | 0.070 |
Why?
|
| Vancomycin | 1 | 2007 | 273 | 0.070 |
Why?
|
| Plasmapheresis | 1 | 2005 | 61 | 0.070 |
Why?
|
| Extracorporeal Circulation | 1 | 2005 | 43 | 0.070 |
Why?
|
| Educational Measurement | 1 | 2008 | 362 | 0.070 |
Why?
|
| Inpatients | 1 | 2010 | 678 | 0.060 |
Why?
|
| Primates | 1 | 2005 | 128 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2010 | 598 | 0.060 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2004 | 44 | 0.060 |
Why?
|
| Rectus Abdominis | 1 | 2005 | 100 | 0.060 |
Why?
|
| Peritoneum | 1 | 2005 | 150 | 0.060 |
Why?
|
| Occupational Exposure | 1 | 2006 | 244 | 0.060 |
Why?
|
| Liver Function Tests | 1 | 2004 | 173 | 0.060 |
Why?
|
| Serum Response Factor | 1 | 2004 | 51 | 0.060 |
Why?
|
| Anesthesia, Local | 1 | 2004 | 66 | 0.060 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2004 | 27 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2007 | 994 | 0.060 |
Why?
|
| HIV | 1 | 2005 | 229 | 0.060 |
Why?
|
| Perfusion | 1 | 2005 | 293 | 0.060 |
Why?
|
| Teaching | 1 | 2006 | 243 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 585 | 0.060 |
Why?
|
| Mitogens | 1 | 2004 | 75 | 0.060 |
Why?
|
| Hematoma | 1 | 2005 | 160 | 0.060 |
Why?
|
| Cholecystectomy | 1 | 2004 | 107 | 0.060 |
Why?
|
| Albumins | 1 | 2005 | 258 | 0.060 |
Why?
|
| Endarterectomy, Carotid | 1 | 2004 | 121 | 0.060 |
Why?
|
| Gallbladder | 1 | 2003 | 69 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2011 | 2203 | 0.060 |
Why?
|
| Cholecystitis | 1 | 2003 | 52 | 0.060 |
Why?
|
| Anesthesiology | 1 | 2005 | 138 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2004 | 224 | 0.060 |
Why?
|
| Immune Tolerance | 1 | 2005 | 403 | 0.060 |
Why?
|
| Ascites | 1 | 2004 | 198 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 1082 | 0.060 |
Why?
|
| Carotid Stenosis | 1 | 2004 | 176 | 0.060 |
Why?
|
| Carcinoma | 2 | 2005 | 2578 | 0.050 |
Why?
|
| Liver Regeneration | 1 | 2003 | 134 | 0.050 |
Why?
|
| Hypercalcemia | 1 | 2003 | 137 | 0.050 |
Why?
|
| Blood Transfusion | 1 | 2005 | 583 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 5437 | 0.050 |
Why?
|
| Prevalence | 1 | 2009 | 3260 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 571 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 860 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2003 | 557 | 0.050 |
Why?
|
| Vasoconstrictor Agents | 1 | 2022 | 151 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2022 | 272 | 0.050 |
Why?
|
| ROC Curve | 1 | 2004 | 1183 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2004 | 584 | 0.050 |
Why?
|
| Swine | 1 | 2005 | 1541 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 639 | 0.050 |
Why?
|
| Angiotensin II | 1 | 2022 | 198 | 0.050 |
Why?
|
| Mass Screening | 1 | 2009 | 1509 | 0.050 |
Why?
|
| Neoplasm Staging | 4 | 2018 | 13658 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2005 | 834 | 0.050 |
Why?
|
| Acute Disease | 2 | 2003 | 2422 | 0.050 |
Why?
|
| Blood Loss, Surgical | 2 | 2013 | 309 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2018 | 2027 | 0.050 |
Why?
|
| Skin | 3 | 2013 | 1259 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2003 | 376 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2005 | 2843 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 4971 | 0.040 |
Why?
|
| Medical Records | 2 | 2011 | 415 | 0.040 |
Why?
|
| Survival Analysis | 3 | 2004 | 9180 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2020 | 337 | 0.040 |
Why?
|
| Young Adult | 2 | 2014 | 21445 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2005 | 945 | 0.040 |
Why?
|
| Fascia | 1 | 2018 | 68 | 0.040 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 1 | 2017 | 3 | 0.040 |
Why?
|
| Administrative Claims, Healthcare | 1 | 2017 | 10 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2004 | 1678 | 0.040 |
Why?
|
| Rehabilitation | 1 | 2017 | 46 | 0.040 |
Why?
|
| Patient Care Bundles | 1 | 2017 | 30 | 0.040 |
Why?
|
| Necrosis | 2 | 2011 | 580 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2005 | 1112 | 0.040 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2018 | 334 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2017 | 228 | 0.030 |
Why?
|
| Cell Division | 3 | 2004 | 2489 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 2488 | 0.030 |
Why?
|
| Lymph Node Excision | 2 | 2013 | 1959 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2013 | 6100 | 0.030 |
Why?
|
| Aging | 1 | 2003 | 1582 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 1085 | 0.030 |
Why?
|
| Lymphoma | 1 | 2002 | 1467 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2006 | 7551 | 0.030 |
Why?
|
| Adolescent | 1 | 2014 | 31252 | 0.030 |
Why?
|
| Bile Duct Neoplasms | 1 | 2018 | 493 | 0.030 |
Why?
|
| Liver | 1 | 2003 | 2961 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 1742 | 0.030 |
Why?
|
| Cholangiocarcinoma | 1 | 2018 | 493 | 0.030 |
Why?
|
| HIV Infections | 1 | 2005 | 2134 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2002 | 5112 | 0.030 |
Why?
|
| Biomarkers | 1 | 2004 | 5047 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2018 | 1987 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2014 | 597 | 0.030 |
Why?
|
| SEER Program | 1 | 2014 | 1000 | 0.020 |
Why?
|
| Rats | 3 | 2004 | 6086 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2011 | 6207 | 0.020 |
Why?
|
| Antisepsis | 1 | 2010 | 12 | 0.020 |
Why?
|
| Personnel Selection | 1 | 2011 | 87 | 0.020 |
Why?
|
| Animals | 5 | 2005 | 59536 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2011 | 665 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 4988 | 0.020 |
Why?
|
| Contraindications | 1 | 2009 | 150 | 0.020 |
Why?
|
| Dissection | 1 | 2009 | 156 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2004 | 11965 | 0.020 |
Why?
|
| Utilization Review | 1 | 2008 | 48 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2010 | 621 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2011 | 703 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2008 | 170 | 0.020 |
Why?
|
| Models, Educational | 1 | 2008 | 95 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2007 | 133 | 0.020 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2008 | 84 | 0.020 |
Why?
|
| Efficiency | 1 | 2008 | 99 | 0.020 |
Why?
|
| Accreditation | 1 | 2008 | 126 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2002 | 3976 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2009 | 371 | 0.020 |
Why?
|
| Hernia, Femoral | 1 | 2006 | 1 | 0.020 |
Why?
|
| Operating Room Nursing | 1 | 2006 | 3 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2009 | 280 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2011 | 661 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 945 | 0.020 |
Why?
|
| Sutures | 1 | 2006 | 86 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2006 | 120 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2006 | 257 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2014 | 1423 | 0.020 |
Why?
|
| Problem-Based Learning | 1 | 2006 | 78 | 0.020 |
Why?
|
| Compartment Syndromes | 1 | 2005 | 30 | 0.020 |
Why?
|
| HIV Antibodies | 1 | 2005 | 102 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2005 | 297 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2009 | 518 | 0.020 |
Why?
|
| Lumbosacral Region | 1 | 2004 | 49 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 2004 | 70 | 0.020 |
Why?
|
| Ilium | 1 | 2004 | 54 | 0.020 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2004 | 8 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2004 | 77 | 0.020 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2004 | 19 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2004 | 28 | 0.020 |
Why?
|
| Protein C | 1 | 2004 | 32 | 0.010 |
Why?
|
| Partial Thromboplastin Time | 1 | 2004 | 55 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2004 | 123 | 0.010 |
Why?
|
| Extracellular Space | 1 | 2004 | 132 | 0.010 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2004 | 68 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 3203 | 0.010 |
Why?
|
| Bone Transplantation | 1 | 2004 | 134 | 0.010 |
Why?
|
| E2F4 Transcription Factor | 1 | 2003 | 30 | 0.010 |
Why?
|
| Genes, Regulator | 1 | 2003 | 69 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2004 | 495 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2004 | 195 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2003 | 224 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 698 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2004 | 246 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 293 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2005 | 671 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 301 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2003 | 629 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2003 | 684 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2006 | 429 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 2003 | 335 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 1099 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 311 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2004 | 576 | 0.010 |
Why?
|
| Genes, myc | 1 | 2003 | 358 | 0.010 |
Why?
|
| Interleukins | 1 | 2004 | 325 | 0.010 |
Why?
|
| Students, Medical | 1 | 2006 | 399 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 703 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2004 | 527 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2013 | 4975 | 0.010 |
Why?
|
| Transcription Factors | 2 | 2004 | 5270 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2011 | 10001 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 2927 | 0.010 |
Why?
|
| Cell Survival | 1 | 2004 | 3045 | 0.010 |
Why?
|
| Biopsy | 1 | 2005 | 3443 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 1498 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2004 | 5395 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2004 | 2054 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 3101 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 4804 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 2359 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 5637 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2003 | 1664 | 0.010 |
Why?
|
| Quality of Life | 1 | 2009 | 4532 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2003 | 1054 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 10035 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 7591 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 4821 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 14551 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 15179 | 0.000 |
Why?
|
| Mice | 1 | 2004 | 34495 | 0.000 |
Why?
|